Clinical study of an Ayurveda formulation containing Gold and Indian Gooseberry along with Tulasi juice as an add on therapy in standard care of COVID 19 patients

INTERVENTION: Intervention1: Swarna Amalaki as an adjuvant therapy: Swarna Amalaki as an adjuvant therapy to standard management of COVID‐19 containing Swarna Bhasma‐ 30mg/day and Amalaki Churna â?? 3gms/day triturated along with fresh juice of Tulasi leaves in powder form will be administered along with honey and ghee once a day in the morning on empty stomach for a period of 28 days. Control Intervention1: Standard management of COVID 19: Standard management as per the ICMR/ MOHFW, Govt. of India/Maharashtra guidelines CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: Early recovery from clinical signs and symptoms such as cough, cold, fever and associated symptoms of COVID 19 without further complications ; ; Negative result for COVID 19 testTimepoint: Baseline,Day7,14,21and 28 SECONDARY OUTCOME: Positive immunomodulation as judged by modification of immunological parameters ‐ IgG, IgM values,CD4 and CD8 cell counts, Absolute Lymphocyte countTimepoint: Baseline and Day 28 INCLUSION CRITERIA: 1. Diagnosed patients of COVID 19with positive RT‐PCR test of either sex, between the age group of 20 ‐70 years 2. Patients of COVID 19 receiving standard treatment protocol as prescribed by ICMR/MOHFW, Govt. of India 3. Patients giving informed consent